advertisement
E-mail Page
Print Format
Google - Traducir esta página a español.
Google - Traduza esta página ao português.
 

  Back to News Research News and Information

Current Research News

    10 April 2013

  1. [New!] Family psychological stress early in life and development of type 1 diabetes: The ABIS prospective study.
  2. [New!] Enteroviral pathogenesis of type 1 diabetes: queries and answers.
  3. [New!] Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.
  4. [New!] Multivariable Adaptive Closed-Loop Control of an Artificial Pancreas Without Meal and Activity Announcement.
  5. [New!] Generation of islet-like cells from mouse gall bladder by direct ex vivo reprogramming.
  6. [New!] Alteration of the thymic T cell repertoire by rotavirus infection is associated with delayed type 1 diabetes development in non-obese diabetic mice. Free full text available in HTML and PDF formats.
  7. [New!] Immunotherapy with Tolerogenic Dendritic Cells Alone or in Combination with Rapamycin Does Not Reverse Diabetes in NOD Mice. Free full text available in HTML and PDF formats.

    3 April 2013

  8. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children.

    27 March 2013

  9. Faster pharmacokinetics and increased patient acceptance of intradermal insulin delivery using a single hollow microneedle in children and adolescents with type 1 diabetes.
  10. Circulating Vitamin D Metabolites and Subclinical Atherosclerosis in Type 1 Diabetes.
  11. Positron emission tomography measured cerebral blood flow and glucose metabolism are decreased in human type 1 diabetes.
  12. Protein intake in relation to risk of hypertension and microalbuminuria in patients with type 1 diabetes: the EURODIAB Prospective Complications Study.
  13. Baseline Markers of Inflammation Are Associated With Progression to Macroalbuminuria in Type 1 Diabetic Subjects.
  14. Factors associated with the presence of glutamic acid decarboxylase and islet antigen-2 autoantibodies in patients with long-standing type 1 diabetes.
  15. Marked Expansion of Exocrine and Endocrine Pancreas with Incretin Therapy in Humans with increased Exocrine Pancreas Dysplasia and the potential for Glucagon-producing Neuroendocrine Tumors.

    20 March 2013

  16. Population-based Survey of the Prevalence of Type 1 and Type 2 diabetes in School Children in Philadelphia.
  17. Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: A randomized, open label study.
  18. Association of the incidence of type 1 diabetes with markers of infection and antibiotic susceptibility at country level. See also Global Rise in Type 1 Diabetes May Be Linked to Reduced Exposure to Pathogens in Early Life.
  19. Fasting and meal-stimulated residual beta cell function is positively associated with serum concentrations of proinflammatory cytokines and negatively associated with anti-inflammatory and regulatory cytokines in patients with longer term type 1 diabetes.
  20. Induced autologous stem cell transplantation for treatment of rabbit type 1 diabetes.
  21. Long-term bisphenol A exposure accelerates insulitis development in diabetes-prone NOD mice.

    13 March 2013

  22. Can C-peptide mediated anti-inflammatory effects retard the development of microvascular complications of type 1 diabetes?
  23. In type 1 diabetes a subset of anti-coxsackievirus b4 antibodies recognize autoantigens and induce apoptosis of pancreatic Beta cells. Free full text available in HTML and PDF formats (link on HTML full text page).
  24. Maintaining functional islets through encapsulation in an injectable saccharide-peptide hydrogel.
  25. The Association between IgG4 Antibodies to Dietary Factors, Islet Autoimmunity and Type 1 Diabetes: The Diabetes Autoimmunity Study in the Young. Free full text available in HTML and PDF formats (link on HTML full text page).
  26. Glucose tolerance and beta-cell function in islet autoantibody-positive children recruited to a secondary prevention study.

    6 March 2013

  27. Nocturnal Glucose Control with an Artificial Pancreas at a Diabetes Camp. See also Artificial Pancreas Worked Overnight on Kids With Type 1 Diabetes.
  28. Overnight automated type 1 diabetes control under MD-logic closed-loop system: a randomized crossover trial.
  29. Does farm environment protect against type 1 diabetes mellitus? Free full text available in HTML and PDF formats.
  30. Identification of a SIRT1 Mutation in a Family with Type 1 Diabetes. See also First single gene mutation shown to result in type 1 diabetes and First Single Gene Mutation Shown to Result in Type 1 Diabetes.
  31. Treatment of diabetes mellitus with microencapsulated fetal human liver (FH-B-TPN) engineered cells.
  32. The Relationship of Sugar to Population-Level Diabetes Prevalence: An Econometric Analysis of Repeated Cross-Sectional Data explores the impact of exposure to sugar on the risk of type 2 diabetes -- still quite relevant to anyone with type 1 diabetes. See also Study: Sugar — Not Obesity — Causes Diabetes and Sugar In Diet Linked To Type 2 Diabetes Rates, Study Finds.
  33. The Diabetes Research Institute announced the DRI BioHub, an artificial organ platform designed to protect islets and provide euglycemia without whole-body immunosuppression, as is required by traditional islet transplants. This announcement of this effort generated heated discussion throughout the online community, not all of it positive. For more, see the following:

    1. This Could Be It.... What We Have Been Waiting For Since Diagnosis!!!!
    2. A Message from Diabetes Dad.
    3. Could it be....
    4. New DRI Mini ‘BioHub’ Organ Would Mimic a Healthy Pancreas.
    5. Hope without hype is all we ask (the one when I wish it started differently).
    6. Don’t Believe the Hype.
    7. News from the DRI.
    8. Our Community.
    9. My Take on the Hub-bub About the Bio Hub.
    10. Empathy. Honoring struggle without trite solutions.
    11. Meanwhile, In Other News....

    27 February 2013

  34. Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. Free full text available in PDF format.
  35. Revisiting the notion of type 1 diabetes being a T-cell-mediated autoimmune disease.
  36. Immune Therapy and beta-Cell Death in Type 1 Diabetes.
  37. Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes.
  38. Proinsulin/Insulin Autoantibodies Measured With Electrochemiluminescent Assay Are the Earliest Indicator of Prediabetic Islet Autoimmunity .
  39. More people needed for type 1 diabetes vaccine study.

    20 February 2013

  40. Allogeneic Bone Marrow Cocultured With Human Islets Significantly Improves Islet Survival and Function In Vivo.
  41. Human milk can neutralize Coxsackievirus B4 in vitro.
  42. Promotion of Autoimmune Diabetes by Cereal Diet in the Presence or Absence of Microbes Associated With Gut Immune Activation, Regulatory Imbalance, and Altered Cathelicidin Antimicrobial Peptide.

    13 February 2013

  43. Treatment of Diabetes and Long-term Survival Following Insulin and Glucokinase Gene Therapy. See also UAB researchers cure type 1 diabetes in dogs, Type 1 Diabetes Cured In Dogs, and Type 1 Diabetes Cured in Dogs, Study Suggests.
  44. Differences in glucose-stimulated insulin secretion in vitro of islets from human, nonhuman primate, and porcine origin.
  45. Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension.
  46. Evidence of Association between Type 1 Diabetes and Exposure to Enterovirus in Cuban Children and Adolescents. Free full text available in PDF format.
  47. A randomized placebo-controlled trial of alphacalcidol on the preservation of beta cell function in children with recent onset type 1 diabetes.

    6 February 2013

  48. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial. Free full text available in PDF format.
  49. Preclinical Serum 25-Hydroxyvitamin D Levels and Risk of Type 1 Diabetes in a Cohort of US Military Personnel. See also ‘Sunshine vitamin’ looks a little brighter.
  50. HLA Class I and II Alleles are Associated with Microvascular Complications of Type 1 Diabetes.
  51. PDX1-engineered embryonic stem cell-derived insulin producing cells regulate hyperglycemia in diabetic mice. Free full text available in HTML and PDF formats.

    30 January 2013

  52. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial. Free full text available in PDF format. See also Artificial pancreas: the way of the future for treating type 1 diabetes.
  53. Promotion of autoimmune diabetes by cereal diet in the presence or absence of microbes associated with gut immune activation, regulatory imbalance and altered cathelicidin antimicrobial peptide .
  54. Verification of Skin Autofluorescence Values by Mass Spectrometry in Adolescents with Type 1 Diabetes: Brief Report.
  55. Previous maternal infection protects offspring from enterovirus infection and prevents experimental diabetes development in mice.

    23 January 2013

  56. Increasing Incidence of Type 1 Diabetes in Youth - Twenty years of the Philadelphia Pediatric Diabetes Registry. See also Type 1 Diabetes in Urban Children Skyrockets.
  57. Prophylactic and Antinociceptive Effects of Coenzyme Q10 on Diabetic Neuropathic Pain in a Mouse Model of Type 1 Diabetes.
  58. Endothelial Progenitor Cells Are Related to Glycemic Control in Children With Type 1 Diabetes Mellitus Over Time.
  59. Macro- or microencapsulation of pig islets to cure type 1 diabetes. Free full text available in HTML and PDF formats.
  60. The Hygiene Theory Harnessing Helminths and Their Ova to Treat Autoimmunity.
  61. Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity. See also Transplanted Gut Bugs Protect Mice from Diabetes and Good Bacteria in the Intestine Prevent Diabetes, Study Suggests.

    16 January 2013

  62. The role of the intestinal microbiota in type 1 diabetes.
  63. Reduction of Number and Duration of Hypoglycemic Events by Glucose Prediction Methods: A Proof-of-Concept In Silico Study.
  64. Hypoglycemia-related electroencephalogram changes are independent of gender, age, duration of diabetes, and awareness status in type 1 diabetes.
  65. Use of an intravascular fluorescent continuous glucose sensor in subjects with type 1 diabetes mellitus.
  66. Neurovascular dysfunction precedes neural dysfunction in the retina of patients with type 1 diabetess.
  67. Cross-Sectional Evaluation of Noninvasively Detected Skin Intrinsic Fluorescence and Mean Hemoglobin A1c in Type 1 Diabetes.
  68. Comparison of annual variability in HbA1c and glycated albumin in patients with type 1 vs. type 2 diabetes mellitus.
  69. Patients with type 1 diabetes exhibit altered cerebral metabolism during hypoglycemia.

    9 January 2013

  70. Helminth mediated modulation of Type 1 diabetes (T1D).
  71. C-peptide in diabetes diagnosis and therapy.
  72. Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus.
  73. Long term reversal of diabetes in non obese diabetic mice by liver-directed gene therapy.
  74. Influence of the vitamin D plasma level and vitamin D-related genetic polymorphisms on the immune status of patients with type 1 diabetes: a pilot study.

    2 January 2013

  75. Fecal Microbiota Composition Differs Between Children With beta-Cell Autoimmunity and Those Without. See also Could prebiotics or probiotics cure type 1 diabetes?
  76. The Effects of n-3 Long-Chain Polyunsaturated Fatty Acid Supplementation on Biomarkers of Kidney Injury in Adults With Diabetes.
  77. The age of onset of diabetes and glutamic acid decarboxylase titer measured long after diagnosis are associated with the clinical stage of slow-onset type 1 diabetes.

    26 December 2012

  78. Integrated Model of Metabolism and Autoimmune Response in beta-Cell Death and Progression to Type 1 Diabetes. Free full text available in HTML and PDF formats.
  79. Combination therapies in the context of anti-CD3 antibodies for the treatment of autoimmune diseases. Free full text available in HTML and PDF formats.
  80. A Case of Slowly Progressive Type 1 Diabetes with Insulin Independence Maintained for 10 Years with alpha-glucosidase Inhibitor Monotherapy. Free full text available in PDF format.

    19 December 2012

  81. Reversal of diabetes in mice with a bioengineered islet implant incorporating a type I collagen hydrogel and sustained release of vascular endothelial growth factor.
  82. Rotavirus acceleration of murine type 1 diabetes is associated with a T helper 1-dependent specific serum antibody response and virus effects in regional lymph nodes.
  83. Engineering antigens for in situ erythrocyte binding induces T-cell deletion. Free full text available in PDF format. See also Autoimmune Disease: Retraining White Blood Cells.
  84. Does modern high standard life style cause Type 1 diabetes in children?
  85. Primary and secondary prevention of Type 1 diabetes.
  86. Role of immune system modulation in prevention of type 1 diabetes mellitus.

    12 December 2012

  87. Molecular anatomy and number of antigen specific CD8 T cells required to cause type 1 diabetes. Free full text available in HTML and PDF formats.
  88. Pancreas Organ Weight in Individuals With Disease-Associated Autoantibodies at Risk for Type 1 Diabetes. See also UF researchers: Understanding pancreas size may help unlock cause of Type 1 diabetes.

    5 December 2012

  89. An Online Failure Detection Method of the Glucose Sensor-Insulin Pump System: Improved Overnight Safety of Type-1 Diabetic Subjects.
  90. Influenza A viruses grow in human pancreatic cells and cause pancreatitis and diabetes in an animal model. See also Diabetes linked to flu.
  91. Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.

    28 November 2012

  92. Closed-Loop Basal Insulin Delivery Over 36 Hours in Adolescents With Type 1 Diabetes.
  93. Clinical Evaluation of a Personalized Artificial Pancreas.
  94. Enhanced Absorption of Insulin Aspart as the Result of a Dispersed Injection Strategy Tested in a Randomized Trial in Type 1 Diabetic Patients.
  95. Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes.
  96. Lower prediagnostic serum 25-hydroxyvitamin D concentration is associated with higher risk of insulin-requiring diabetes: a nested case–control study. See also Low Vitamin D Level Tied to Type 1 Diabetes.
  97. Metformin Improves Endothelial Function in Type 1 Diabetic Subjects: A Pilot, Placebo-Controlled Randomized Study.
  98. High fructose corn syrup and diabetes prevalence: A global perspective. Free full text available in PDF format. See also Diabetes and Sweetener Link Scrutinized.

    21 November 2012

  99. Islet-Specific CTL Cloned from a Type 1 Diabetes Patient Cause Beta-Cell Destruction after Engraftment into HLA-A2 Transgenic NOD/SCID/IL2RG Null Mice. Free full text available in HTML and PDF formats.
  100. Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. Free full text available in PDF format.
  101. Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. See also Nanoparticle treatment could combat type 1 diabetes.
  102. Reduction in Carotid Intima-Media Thickness After Pancreatic Islet Transplantation in Patients With Type 1 Diabetes.
  103. HLA-A*24 Is an Independent Predictor of 5-Year Progression to Diabetes in Autoantibody-Positive First-Degree Relatives of Type 1 Diabetic Patients.
  104. Family history of Type 1 diabetes affects insulin secretion in patients with 'Type 2' diabetes.
  105. Long-Term Changes in Adiposity and Glycemic Control Are Associated With Past Adenovirus Infection.
  106. Recent incidence of type 1 diabetes mellitus in children 0--14 years in Newfoundland and Labrador, Canada climbs to over 45/100,000: a retrospective time trend study. Free full text available in PDF format.

    14 November 2012

  107. Adult Pancreas Side Population Cells Expand after beta Cell Injury and Are a Source of Insulin-Secreting Cells. See also Pancreas stem cell discovery may lead to new diabetes treatments.
  108. White Matter Microstructural Integrity in Youth With Type 1 Diabetes.
  109. Periodic Extraction of Interstitial Fluid from the Site of Subcutaneous Insulin Infusion for the Measurement of Glucose: A Novel Single-Port Technique for the Treatment of Type 1 Diabetes Patients.
  110. Delayed Small Intestinal Transit in Patients with Long-Standing Type 1 Diabetes Mellitus: Investigation of the Relationships with Clinical Features, Gastric Emptying, Psychological Distress, and Nutritional Parameters.

    7 November 2012

  111. Can we vaccinate against Type 1 diabetes? Free full text available in HTML and PDF formats.
  112. From biomarkers to a clue of biology: a computation-aided perspective of immune gene expression profiles in human type 1 diabetes. Free full text available in HTML and PDF formats.
  113. Novel therapies in the management of type I diabetes mellitus.
  114. Diabetes Death Rates Among Youths Aged <=19 Years — United States, 1968–2009.
  115. High prevalence of vitamin D deficiency among newly diagnosed youth-onset diabetes mellitus in north India. Free full text available in HTML and PDF formats.

    31 October 2012

  116. Real-time assessment of encapsulated neonatal porcine islets prior to clinical xenotransplantation.
  117. Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer.

    24 October 2012

  118. Early Life Socioeconomic Indicators and Risk of Type 1 Diabetes in Children and Young Adults.
  119. Residual beta cell function at diagnosis of Type 1 diabetes in children and adolescents varies with gender and season.
  120. Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial.
  121. The broad clinical phenotype of Type 1 diabetes at presentation.

    18 October 2012

  122. Effect of insulin feedback on closed-loop glucose control: a crossover study.
  123. Feasibility of a bihormonal closed-loop system to control postexercise and postprandial glucose excursions.
  124. Robust fault detection system for insulin pump therapy using continuous glucose monitoring.
  125. Inpatient studies of a Kalman-filter-based predictive pump shutoff algorithm.
  126. Diabetic ketoacidosis at diagnosis: role of family history and class II HLA genotypes.

    10 October 2012

  127. Comparative Pharmacokinetics and Insulin Action for Three Rapid-Acting Insulin Analogs Injected Subcutaneously With and Without Hyaluronidase.
  128. Macroporous Three Dimensional PDMS Scaffolds for Extrahepatic Islet Transplantation.
  129. New susceptibility Loci associated with kidney disease in type 1 diabetes. Free full text available in HTML and PDF formats.
  130. Early Childhood Infections and the Risk of Islet Autoimmunity - The Diabetes Autoimmunity Study in the Young (DAISY).
  131. Therapeutic Effects of PPARalpha Agonists on Diabetic Retinopathy in Type 1 Diabetic Models.
  132. Participant characteristics and study features associated with high retention rates in a longitudinal investigation of type 1 diabetes mellitus.

    3 October 2012

  133. Closed-Loop Insulin Therapy Improves Glycemic Control in Children Aged <7 Years.
  134. Extended Family History of Type 1 Diabetes and Phenotype and Genotype of Newly Diagnosed Children.
  135. Pancreatic beta Cell Dedifferentiation as a Mechanism of Diabetic beta Cell Failure.
  136. Pancreas survival in simultaneous pancreas-kidney and pancreas-after-kidney transplantations: A five-year follow-up report.
  137. Rising Incidence of Type 1 Diabetes in Belgrade Children Aged 0-14 in the Period From 1982 to 2005.
  138. Use of continuous glucose monitoring as an outcome measure in clinical trials.
  139. Evaluation of a Novel Continuous Glucose Monitoring-Based Method for Mealtime Insulin Dosing-the iBolus-in Subjects with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion Therapy: A Randomized Controlled Trial.
  140. Sleep disturbances and low psychological well-being are associated with an increased risk of autoimmune diabetes in adults. Results from the Nord-Trøndelag Health Study.
  141. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Free full text available in HTML and PDF formats.

    26 September 2012

  142. Remogliflozin Etabonate, a Selective Inhibitor of the Sodium-Glucose Transporter 2, Improves Serum Glucose Profiles in Type 1 Diabetes.
  143. Continuous Glucose Monitoring after Islet Transplantation in Type 1 Diabetes: An Excellent Graft Function (beta-Score Greater Than 7) Is Required to Abrogate Hyperglycemia, Whereas a Minimal Function Is Necessary to Suppress Severe Hypoglycemia (beta-Score Greater Than 3).
  144. The microbiology of human hygiene and its impact on type 1 diabetes.
  145. Prevention of Virus-Induced Type 1 Diabetes with Antibiotic Therapy.
  146. The T1D Exchange Clinic Registry.
  147. Modified release terbutaline (SKP1052) for hypoglycemia prevention: A proof-of-concept study in people with type 1 diabetes mellitus. See also Terbutaline and the prevention of nocturnal hypoglycemia in type 1 diabetes, previously reported (PDF).

    19 September 2012

  148. Stem cells as a tool to improve outcomes of islet transplantation. Free full text available in HTML and PDF formats.
  149. Glucagon secretion and signaling in the development of diabetes. Free full text available in HTML and PDF formats.
  150. Enterovirus-induced gene expression profile is critical for human pancreatic islet destruction.
  151. Teplizumab for Treatment of Type 1 Diabetes Mellitus.

    12 September 2012

  152. On the Etiology of Type 1 Diabetes: A New Animal Model Signifying a Decisive Role for Bacteria Eliciting an Adverse Innate Immunity Response.
  153. White Matter Structural Differences in Young Children With Type 1 Diabetes: A Diffusion Tensor Imaging Study.
  154. Current evidence on the associations of breastfeeding, infant formula, and cow's milk introduction with type 1 diabetes mellitus: a systematic review.
  155. Dysregulated Toll-Like Receptor–Induced Interleukin-1beta and Interleukin-6 Responses in Subjects at Risk for the Development of Type 1 Diabetes.
  156. The BH3-Only Proteins Bim and Puma Cooperate to Impose Deletional Tolerance of Organ-Specific Antigens. See also Immune cell death safeguards against autoimmune disease and Proteins offer protection from type 1 diabetes.

    5 September 2012

  157. Maturation of Human Embryonic Stem Cell–Derived Pancreatic Progenitors Into Functional Islets Capable of Treating Pre-existing Diabetes in Mice. See also UBC scientists reverse diabetes in mice using stem-cell transplants.
  158. Insulin resistance in multiple tissues in patients with type 1 diabetes mellitus on long term continuous subcutaneous insulin infusion therapy.
  159. A strategy for combining minor genetic susceptibility genes to improve prediction of disease in type 1 diabetes.
  160. Type I diabetes among children and young adults: the role of country of birth, socioeconomic position and sex.
  161. Factors That Influence Parental Attitudes toward Enrollment in Type 1 Diabetes Trials. Free full text available in HTML and PDF formats.

    30 August 2012

  162. Blood Glucose Control in Type 1 Diabetes With a Bihormonal Bionic Endocrine Pancreas.
  163. A fluorescent responsive hybrid nanogel for closed-loop control of glucose.
  164. Pharmacokinetics and Postprandial Glycemic Excursions following Insulin Lispro Delivered by Intradermal Microneedle or Subcutaneous Infusion.
  165. Islet beta-Cell Mass Preservation and Regeneration in Diabetes Mellitus: Four Factors with Potential Therapeutic Interest. Free full text available in HTML and PDF formats (PDF link in HTML page).
  166. Increasing local blood flow by warming the application site: beneficial effects on postprandial glycemic excursions.
  167. Insulin Degludec/Insulin Aspart Administered Once Daily at Any Meal, With Insulin Aspart at Other Meals Versus a Standard Basal-Bolus Regimen in Patients With Type 1 Diabetes.
  168. Relationship between diabetic retinopathy, microalbuminuria and overt nephropathy, and twenty-year incidence follow-up of a sample of type 1 diabetic patients.
  169. Complications of continuous intraperitoneal insulin infusion with an implantable pump. Free full text available in HTML and PDF formats.

    22 August 2012

  170. Proof-of-Concept, Randomized, Controlled Clinical Trial of Bacillus-Calmette-Guerin for Treatment of Long-Term Type 1 Diabetes. Free full text available in HTML format with link to PDF.
  171. Human embryonic stem cell differentiation into insulin secreting beta cells for diabetes. Free full text available in PDF format.
  172. Three-Dimensional Scaffolds Reduce Islet Amyloid Formation and Enhance Survival and Function of Cultured Human Islets.
  173. The Non-Obese Diabetic (NOD) Mouse as a Model of Human Type 1 Diabetes.
  174. The BB Rat as a Model of Human Type 1 Diabetes.

    8 August 2012

  175. Feasibility Study of Automated Overnight Closed-Loop Glucose Control Under MD-Logic Artificial Pancreas in Patients with Type 1 Diabetes: The DREAM Project.
  176. The Use of an Automated, Portable, Glucose Control System for Overnight Glucose Control in Adolescents and Young Adults With Type 1 Diabetes.
  177. Vildagliptin Reduces Glucagon during Hyperglycemia and Sustains Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes.
  178. Systemic exposure to Pseudomonal bacteria: a potential link between type 1 diabetes and chronic inflammation.
  179. Patient Perspectives on Personalized Glucose Advisory Systems for Type 1 Diabetes Management.
  180. Immunotherapy for Type 1 diabetes: getting beyond a negative first impression.

    1 August 2012

  181. Improvements in the life expectancy of type 1 diabetes; The Pittsburgh Epidemiology of Diabetes Complications Study cohort.
  182. Breast-Feeding and Childhood-Onset Type 1 Diabetes; A pooled analysis of individual participant data from 43 observational studies.
  183. The Effect of Direct Renin Inhibition Alone and in Combination With ACE Inhibition on Endothelial Function, Arterial Stiffness, and Renal Function in Type 1 Diabetes.
  184. History of Cesarean Section Associated with Childhood Onset of T1DM in Newfoundland and Labrador, Canada. Free full text available in HTML and PDF formats.
  185. In vitro generation of functional insulin-producing cells from human bone marrow-derived stem cells, but long-term culture running risk of malignant transformation. Free full text available in HTML and PDF formats.

[ Current Research News | News from 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 ]



 
Not Helpful  1 2 3 4 5  Very Helpful                  E-mail Article E-mail Page     Printer Friendly format Print Format    
  Home Return to Top

Last Updated: Wednesday April 10, 2013 16:13:39
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

US Flag This site is published by Children With Diabetes, Inc, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, Privacy Policy, and Safe Harbor Policy.
© Children with Diabetes, Inc. 1995-2013. Comments and Feedback.